On May 14th, 2024, the Biden administration introduced punitive tariffs on many medical products imported from China. This move, aimed at addressing perceived “unfair trade practices,” carries a hefty price tag, with the tariff rate on essential items such as syringes and needles made in China skyrocketing from 0% to 50%.
While this undoubtedly presents a challenge, it also compels companies to explore alternative sourcing options. India is one of these such countries. In 2022, an IndexBox report cited India as the fastest growing syringe supplier in the world. The disposable syringe market in India was valued at over $400 Million in 2023.
Today, India has a strong manufacturing base in a variety of fields, including medical devices. In fact, Indian makers have a long history of supplying medical disposables to their domestic market and to Africa, southeast Asia and Eastern Europe. During the Covid 19 pandemic many upgraded their facilities and practices to the needs of developed country markets. Because India has a low cost of manufacturing and many skilled employees, forward thinking companies are turning to India as an alternative to China.
If you’re looking to secure reliable and affordable medical supplies in the face of these new tariffs, consider exploring the Indian supplier base. Amritt Inc. can help navigate this transition. We offer free informational consultations designed to guide you through the process of sourcing syringes and other medical products from India. Don’t hesitate to contact us today and learn how you can build a more resilient supply chain for medical syringes, needles and related supplies